Is NTUS undervalued or overvalued?
As of 2025-03-23, the Intrinsic Value of Natus Medical Inc (NTUS) is 7.51 USD. This NTUS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 32.96 USD, the upside of Natus Medical Inc is -77.20%. This means that NTUS is overvalued by 77.20%.
The range of the Intrinsic Value is 6.33 - 9.97 USD
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 6.33 - 9.97 | 7.51 | -77.2% |
DCF (Growth 10y) | 6.83 - 10.36 | 7.99 | -75.7% |
DCF (EBITDA 5y) | 10.33 - 13.59 | 12.03 | -63.5% |
DCF (EBITDA 10y) | 9.18 - 12.93 | 11.02 | -66.6% |
Fair Value | 3.33 - 3.33 | 3.33 | -89.89% |
P/E | 5.93 - 12.27 | 8.96 | -72.8% |
EV/EBITDA | 12.05 - 31.54 | 21.03 | -36.2% |
EPV | 15.99 - 20.65 | 18.32 | -44.4% |
DDM - Stable | 2.99 - 7.97 | 5.48 | -83.4% |
DDM - Multi | 3.54 - 7.46 | 4.81 | -85.4% |
Market Cap (mil) | 1,139.85 |
Beta | 0.23 |
Outstanding shares (mil) | 34.58 |
Enterprise Value (mil) | 1,139.85 |
Market risk premium | 4.24% |
Cost of Equity | 8.36% |
Cost of Debt | 4.25% |
WACC | 8.36% |